Pharmacological concentrations of the HMG-COA reductase inhibitor lovastatin decrease the formation of the Alzheimer beta -amyloid peptide em in vitro em and in patients
Year: 2002
Type: article
Study design: Clinical Trial
Source: Frontiers in bioscience
DOI: 10.2741/a739
Institutions: Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W281248207
